[1] SIEGEL I,LIU T L,GLEICHER N.The red-cell immune system[J]. Lancet,1981,2(8246):556-559. [2] ANDERSON H L,BRODSKY I E,MANGALMURTI N S.The evolving erythrocyte: red blood cells as modulators of innate immunity[J]. J Immunol,2018,201(5):1343-1351. [3] BASTA F,FASOLA F,TRIANTAFYLLIAS K,et al.Systemic lupus erythematosus (SLE) therapy:the old and the new[J]. Rheumatol Ther,2020,7(3):433-446. [4] XU C L,HE J,WANG H T,et al.Single-cell transcriptomic analysis identifies an immune-prone population in erythroid precursors during human ontogenesis[J].Nat Immunol,2022,23(7):1109-1120. [5] ZHAO L T,HE R,LONG H X,et al.Late-stage tumors induce Anemia and immunosuppressive extramedullary erythroid progenitor cells[J]. Nat Med,2018,24(10):1536-1544. [6] HOTZ M J,QING D,SHASHATY M G S,et al. Red blood cells homeostatically bind mitochondrial DNA through TLR9 to maintain quiescence and to prevent lung injury[J].Am J Respir Crit Care Med,2018,197(4):470-480. [7] METTHEW LAM L K M,MURPHY S,KOKKINAKI D,et al. DNA binding to TLR9 expressed by red blood cells promotes innate immune activation and Anemia[J]. Sci Transl Med,2021,13(616):eabj1008. [8] BINDER C,CVETKOVSKI F,SELLBERG F,et al.CD2 immunobiology[J]. Front Immunol,2020,11:1090. [9] ZHANG Y L,LIU Q F,YANG S,et al.CD58 immunobiology at a glance[J]. Front Immunol, 2021,12:705260. [10] GHEIBIHAYAT S M,CABEZAS R,NIKIFOROV N G,et al.CD47 in the brain and neurodegeneration:an update on the role in neuroinflammatory pathways[J]. Molecules,2021,26(13):3943. [11] KAZAMA R,MIYOSHI H,TAKEUCHI M,et al.Combination of CD47 and signal-regulatory protein-α constituting the “don't eat me signal” is a prognostic factor in diffuse large B-cell lymphoma[J]. Cancer Sci,2020,111(7):2608-2619. [12] WANG F,LIU Y H,ZHANG T,et al.Aging-associated changes in CD47 arrangement and interaction with thrombospondin-1 on red blood cells visualized by super-resolution imaging[J]. Aging Cell,2020,19(10):e13224. [13] OLIVEIRA L C,KRETZSCHMAR G C,DOS SANTOS A C M,et al. Complement receptor 1 (CR1,CD35) polymorphisms and soluble CR1:a proposed anti-inflammatory role to quench the fire of “fogo selvagem” Pemphigus foliaceus[J]. Front Immunol, 2019,10:2585. [14] OLIVEIRA L C,KRETZSCHMAR G C,DOS SANTOS A C M,et al. Complement receptor 1 (CR1,CD35) polymorphisms and soluble CR1:a proposed anti-inflammatory role to quench the fire of “fogo selvagem” Pemphigus foliaceus[J]. Front Immunol,2019,10:2585. [15] KISSERLI A,SCHNEIDER N,AUDONNET S,et al.Acquired decrease of the C3b/C4b receptor (CR1,CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients[J]. Immunobiology, 2021,226(3):152093. [16] BOERO E,GORHAM R D Jr,FRANCIS E A,et al. Purified complement C3b triggers phagocytosis and activation of human neutrophils via complement receptor 1[J]. Sci Rep,2023,13(1):274. [17] ASOK KUMAR N,MURALEEDHARAN SUMA S,KUNNAKKADAN U,et al.Functional dissection of the dominant role of CD55 in protecting vesicular stomatitis virus against complement-mediated neutralization[J].Viruses,2021,13(3):373. [18] COLDEN M A,KUMAR S,MUNKHBILEG B,et al.Insights into the emergence of paroxysmal nocturnal hemoglobinuria[J]. Front Immunol,2022,12:830172. [19] SHAKYA B,PATEL S D,TANI Y,et al.Erythrocyte CD55 mediates the internalization of Plasmodium falciparum parasites[J]. eLife,2021,10:e61516. [20] BHARTI R,DEY G,LIN F,et al.CD55 in cancer: Complementing functions in a non-canonical manner[J]. Cancer Lett,2022,551:215935. [21] YIN X N,SHEN C Y,YIN Y,et al.Overexpression of CD55 correlates with tumor progression and poor prognosis in gastric stromal tumors[J]. Onco Targets Ther,2019,12:4703-4712. [22] WEINSTOCK C.Association of blood group antigen CD59 with disease[J]. Transfus Med Hemother,2022,49(1):13-24. [23] ZHANG R H,LIU Q F,LIAO Q,et al.CD59:a promising target for tumor immunotherapy[J]. Future Oncol,2018,14(8):781-791. [24] VAN ALSTEN S C,AVERSA J G,SANTO L,et al. Association between ABO and Duffy blood types and circulating chemokines and cytokines[J]. Genes Immun,2021,22(3):161-171. [25] REN Y J,YAN C K,YANG H.Erythrocytes:Member of the immune system that should not be ignored[J]. Crit Rev Oncol Hematol,2023,187:104039. [26] HILLARY R F,TREJO-BANOS D,KOUSATHANAS A,et al.Multi-method genome-and epigenome-wide studies of inflammatory protein levels in healthy older adults[J]. Genome Med,2020,12(1):60. [27] KLEI T R L,AGLIALORO F,MUL F P J,et al. Differential interaction between DARC and SDF-1 on erythrocytes and their precursors[J]. Sci Rep,2019,9(1):16245. [28] ELAHI S.Neglected cells:immunomodulatory roles of CD71+ erythroid cells[J]. Trends Immunol, 2019,40(3):181-185. [29] ELAHI S,VEGA-LÓPEZ M A,HERMAN-MIGUEL V,et al. CD71+ erythroid cells in human neonates exhibit immunosuppressive properties and compromise immune response against systemic infection in neonatal mice[J]. Front Immunol,2020,11:597433. [30] GRZYWA T M,NOWIS D,GOLAB J.The role of CD71+ erythroid cells in the regulation of the immune response[J]. Pharmacol Ther,2021,228:107927. [31] MILLER D,ROMERO R,UNKEL R,et al.CD71+ erythroid cells from neonates born to women with preterm labor regulate cytokine and cellular responses[J]. J Leukoc Biol,2018,103(4):761-775. [32] DELYEA C,BOZORGMEHR N,KOLEVA P,et al.CD71+ erythroid suppressor cells promote fetomaternal tolerance through arginase-2 and PDL-1[J]. J Immunol, 2018,200(12):4044-4058. [33] 李悦,石莉红. 红细胞免疫调控功能的研究进展[J]. 中国细胞生物学学报,2022,44(1):59-67. |